<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02613299</url>
  </required_header>
  <id_info>
    <org_study_id>15-007644</org_study_id>
    <nct_id>NCT02613299</nct_id>
  </id_info>
  <brief_title>Surgery for Mesothelioma After Radiation Therapy &quot;SMART&quot; for Resectable Malignant Pleural Mesothelioma</brief_title>
  <official_title>Surgery for Mesothelioma After Radiation Therapy &quot;SMART&quot; for Resectable Malignant Pleural Mesothelioma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether radiation therapy decreases tumor size and&#xD;
      tumor spread. The investigators will consent subjects that have been diagnosed with&#xD;
      mesothelioma and will undergo radiation therapy followed by surgical resection as their&#xD;
      standard of care. The investigators will collect data from past and future medical records as&#xD;
      well as data regarding their health status for their lifetime by reviewing life status,&#xD;
      treatment status and CT scans.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survival status upon review of patient records every 6 months</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Mesothelioma</condition>
  <condition>Solitary Fibrous Tumor of the Pleura</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients receiving treatment at the Mayo Clinic Rochester that have been diagnosed with&#xD;
        mesothelioma and will undergo radiation therapy followed by surgical resection as their&#xD;
        standard of care.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject provides informed consent&#xD;
&#xD;
          -  Subject is &gt;18 years of age&#xD;
&#xD;
          -  Subject is deemed competent for making medical decisions&#xD;
&#xD;
          -  Subject is scheduled to undergo radiation followed by extrapleural pneumonectomy.&#xD;
&#xD;
          -  Subject is a surgical candidate&#xD;
&#xD;
          -  A negative pregnancy test is required in women of child-bearing potential, as standard&#xD;
             of care.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject is &lt;18 years old.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dennis Wigle, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karlyn Pierson, RN</last_name>
    <phone>507-293-0807</phone>
    <email>pierson.karlyn@mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bettie Lechtenberg, MBA</last_name>
    <phone>507-293-0807</phone>
    <email>lechtenberg.bettie@mayo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karlyn E Pierson, RN</last_name>
      <phone>507-538-1960</phone>
      <email>pierson.karlyn@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Dennis A Wigle, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>November 20, 2015</study_first_submitted>
  <study_first_submitted_qc>November 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 24, 2015</study_first_posted>
  <last_update_submitted>September 13, 2021</last_update_submitted>
  <last_update_submitted_qc>September 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Dennis Wigle</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mesothelioma</mesh_term>
    <mesh_term>Mesothelioma, Malignant</mesh_term>
    <mesh_term>Solitary Fibrous Tumors</mesh_term>
    <mesh_term>Neoplasms, Fibrous Tissue</mesh_term>
    <mesh_term>Solitary Fibrous Tumor, Pleural</mesh_term>
    <mesh_term>Pleural Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

